Literature DB >> 19300181

The innate immune response and activation of coagulation in alpha1,3-galactosyltransferase gene-knockout xenograft recipients.

Mohamed Ezzelarab1, Bertha Garcia, Agnes Azimzadeh, Hongtao Sun, Chih Che Lin, Hidetaka Hara, Sean Kelishadi, Tianshu Zhang, Yih Jyh Lin, Hao-Chi Tai, Robert Wagner, Jnanesh Thacker, Noriko Murase, Kenneth McCurry, Rolf N Barth, David Ayares, Richard N Pierson, David K C Cooper.   

Abstract

BACKGROUND: The role of the innate immune system in the development of thrombotic microangiopathy (TM) after alpha1,3-galactosyltransferase gene-knockout (GTKO) pig organ transplantation in primates is uncertain.
METHODS: Twelve organs (nine hearts, three kidneys) from GTKO pigs were transplanted into baboons that received no immunosuppressive therapy, partial regimens, or a full regimen based on costimulation blockade. After graft failure, histologic and immunohistologic examinations were carried out.
RESULTS: Graft survival of less than 1 day was prolonged to 2 to 12 days with partial regimens (acute humoral xenograft rejection) and to 5 and 8 weeks with the full regimen (TM). Clinical or laboratory features of consumptive coagulopathy occurred in 7 of 12 baboons. Immunohistochemistry demonstrated IgM, IgG, and complement deposition in most cases. Histopathology demonstrated neutrophil and macrophage infiltrates, intravascular fibrin deposition, and platelet aggregation (TM). Grafts showed expression of primate tissue factor (TF), with increased mRNA levels, and TF was also expressed on baboon macrophages/monocytes infiltrating the graft.
CONCLUSIONS: Our data suggest that (1) irrespective of the presence or absence of the adaptive immune response, early or late xenograft rejection is associated with activation of the innate immune system; and (2) porcine endothelial cell activation and primate TF expression by recipient innate immune cells may both contribute to the development of TM.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19300181      PMCID: PMC4135362          DOI: 10.1097/TP.0b013e318199c34f

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  46 in total

1.  T cell-activated macrophages are capable of both recognition and rejection of pancreatic islet xenografts.

Authors:  Shounan Yi; Wayne J Hawthorne; Anne M Lehnert; Hong Ha; Jeferey Kwok Wah Wong; Nico van Rooijen; Kelly Davey; Anita T Patel; Stacey N Walters; Abhilash Chandra; Philip J O'Connell
Journal:  J Immunol       Date:  2003-03-01       Impact factor: 5.422

2.  Anti-CD154 monoclonal antibody and thromboembolism revisted.

Authors:  Christoph Knosalla; Bernd Gollackner; David K Cooper
Journal:  Transplantation       Date:  2002-08-15       Impact factor: 4.939

3.  alpha1,3-Galactosyltransferase gene-knockout pig heart transplantation in baboons with survival approaching 6 months.

Authors:  Yau-Lin Tseng; Kenji Kuwaki; Frank J M F Dor; Akira Shimizu; Stuart Houser; Yosuke Hisashi; Kazuhiko Yamada; Simon C Robson; Michel Awwad; Henk-Jan Schuurman; David H Sachs; David K C Cooper
Journal:  Transplantation       Date:  2005-11-27       Impact factor: 4.939

4.  Acute rejection is associated with antibodies to non-Gal antigens in baboons using Gal-knockout pig kidneys.

Authors:  Gang Chen; Hua Qian; Thomas Starzl; Hongtao Sun; Bertha Garcia; Ximo Wang; Yishai Wise; Yuanqing Liu; Ying Xiang; Laura Copeman; Weihua Liu; Anthony Jevnikar; William Wall; David K C Cooper; Noriko Murase; Yifan Dai; Wanyu Wang; Yuliang Xiong; David J White; Robert Zhong
Journal:  Nat Med       Date:  2005-11-27       Impact factor: 53.440

5.  Targeted disruption of the alpha1,3-galactosyltransferase gene in cloned pigs.

Authors:  Yifan Dai; Todd D Vaught; Jeremy Boone; Shu-Hung Chen; Carol J Phelps; Suyapa Ball; Jeff A Monahan; Peter M Jobst; Kenneth J McCreath; Ashley E Lamborn; Jamie L Cowell-Lucero; Kevin D Wells; Alan Colman; Irina A Polejaeva; David L Ayares
Journal:  Nat Biotechnol       Date:  2002-03       Impact factor: 54.908

6.  Production of alpha 1,3-galactosyltransferase-deficient pigs.

Authors:  Carol J Phelps; Chihiro Koike; Todd D Vaught; Jeremy Boone; Kevin D Wells; Shu-Hung Chen; Suyapa Ball; Susan M Specht; Irina A Polejaeva; Jeff A Monahan; Pete M Jobst; Sugandha B Sharma; Ashley E Lamborn; Amy S Garst; Marilyn Moore; Anthony J Demetris; William A Rudert; Rita Bottino; Suzanne Bertera; Massimo Trucco; Thomas E Starzl; Yifan Dai; David L Ayares
Journal:  Science       Date:  2002-12-19       Impact factor: 47.728

7.  Production of alpha-1,3-galactosyltransferase null pigs by means of nuclear transfer with fibroblasts bearing loss of heterozygosity mutations.

Authors:  Donna Kolber-Simonds; Liangxue Lai; Steven R Watt; Maria Denaro; Scott Arn; Monica L Augenstein; Jeffery Betthauser; David B Carter; Julia L Greenstein; Yanhong Hao; Gi-Sun Im; Zhonghua Liu; Greg D Mell; Clifton N Murphy; Kwang-Wook Park; August Rieke; David J J Ryan; David H Sachs; Erik J Forsberg; Randall S Prather; Robert J Hawley
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-03       Impact factor: 11.205

8.  Suppression of natural and elicited antibodies in pig-to-baboon heart transplantation using a human anti-human CD154 mAb-based regimen.

Authors:  Kenji Kuwaki; Christoph Knosalla; Frank J M F Dor; Bernd Gollackner; Yau-Lin Tseng; Stuart Houser; Nicolas Mueller; Derek Prabharasuth; Amy Alt; Kathy Moran; Jane Cheng; Amir Behdad; David H Sachs; Jay A Fishman; Henk-Jan Schuurman; Michel Awwad; David K C Cooper
Journal:  Am J Transplant       Date:  2004-03       Impact factor: 8.086

9.  Correlation of biochemical and hematological changes with graft failure following pig heart and kidney transplantation in baboons.

Authors:  Christoph Knosalla; Bernd Gollackner; Leo Bühler; Nicolas J Mueller; Stuart Houser; Shamila Mauiyyedi; David H Sachs; Simon C Robson; Jay Fishman; Henk-Jan Schuurman; Michel Awwad; David K C Cooper
Journal:  Am J Transplant       Date:  2003-12       Impact factor: 8.086

Review 10.  Thrombin: a potential proinflammatory mediator in neurotrauma and neurodegenerative disorders.

Authors:  Z Suo; B A Citron; B W Festoff
Journal:  Curr Drug Targets Inflamm Allergy       Date:  2004-03
View more
  66 in total

1.  Preparation and physical properties of a novel biocompatible porcine corneal acellularized matrix.

Authors:  Yi Shao; Luowa Quyang; Yueping Zhou; Jing Tang; Yuehui Tan; Qiuping Liu; Zhirong Lin; Tingting Yin; Fangfang Qiu; Zuguo Liu
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-06-09       Impact factor: 2.416

2.  Recipient tissue factor expression is associated with consumptive coagulopathy in pig-to-primate kidney xenotransplantation.

Authors:  C C Lin; M Ezzelarab; R Shapiro; B Ekser; C Long; H Hara; G Echeverri; C Torres; H Watanabe; D Ayares; A Dorling; D K C Cooper
Journal:  Am J Transplant       Date:  2010-07       Impact factor: 8.086

3.  Minimal effect of bortezomib in reducing anti-pig antibodies in human leukocyte antigen-sensitized patients: a pilot study.

Authors:  Hidetaka Hara; Andrew Bentall; Cassandra Long; Jason Fang; Oleg Andreyev; John Lunz; Mohamed Ezzelarab; Kareem M Abu-Elmagd; Ron Shapiro; David Ayares; Mark Stegall; David K C Cooper
Journal:  Xenotransplantation       Date:  2013-09-03       Impact factor: 3.907

Review 4.  Which anti-platelet therapies might be beneficial in xenotransplantation?

Authors:  Moritz Schmelzle; Peter J Cowan; Simon C Robson
Journal:  Xenotransplantation       Date:  2011 Mar-Apr       Impact factor: 3.907

5.  An Investigation of Extracellular Histones in Pig-To-Baboon Organ Xenotransplantation.

Authors:  Tao Li; Whayoung Lee; Hidetaka Hara; Cassandra Long; Mohamed Ezzelarab; David Ayares; Hai Huang; Yi Wang; Charles T Esmon; David K C Cooper; Hayato Iwase
Journal:  Transplantation       Date:  2017-10       Impact factor: 4.939

6.  Early graft failure of GalTKO pig organs in baboons is reduced by expression of a human complement pathway-regulatory protein.

Authors:  Agnes M Azimzadeh; Sean S Kelishadi; Mohamed B Ezzelarab; Avneesh K Singh; Tiffany Stoddard; Hayato Iwase; Tianshu Zhang; Lars Burdorf; Evelyn Sievert; Chris Avon; Xiangfei Cheng; David Ayares; Keith A Horvath; Philip C Corcoran; Muhammad M Mohiuddin; Rolf N Barth; David K C Cooper; Richard N Pierson
Journal:  Xenotransplantation       Date:  2015-07-14       Impact factor: 3.907

7.  Pig-to-baboon heterotopic heart transplantation--exploratory preliminary experience with pigs transgenic for human thrombomodulin and comparison of three costimulation blockade-based regimens.

Authors:  Hayato Iwase; Burcin Ekser; Vikas Satyananda; Jay Bhama; Hidetaka Hara; Mohamed Ezzelarab; Edwin Klein; Robert Wagner; Cassandra Long; Jnanesh Thacker; Jiang Li; Hao Zhou; Maolin Jiang; Santosh Nagaraju; Huidong Zhou; Massimiliano Veroux; Pietro Bajona; Martin Wijkstrom; Yi Wang; Carol Phelps; Nikolai Klymiuk; Eckhard Wolf; David Ayares; David K C Cooper
Journal:  Xenotransplantation       Date:  2015-04-03       Impact factor: 3.907

8.  Rhesus monkeys and baboons develop clotting factor VIII inhibitors in response to porcine endothelial cells or islets.

Authors:  John M Stewart; Alice F Tarantal; Wayne J Hawthorne; Evelyn J Salvaris; Philip J O'Connell; Mark B Nottle; Anthony J F d'Apice; Peter J Cowan; Mary Kearns-Jonker
Journal:  Xenotransplantation       Date:  2014-05-08       Impact factor: 3.907

9.  Costimulation blockade in pig artery patch xenotransplantation - a simple model to monitor the adaptive immune response in nonhuman primates.

Authors:  Mohamed B Ezzelarab; Burcin Ekser; Gabriel Echeverri; Hidetaka Hara; Corin Ezzelarab; Cassandra Long; Pietro Bajona; Bertha Garcia; Noriko Murase; David Ayares; David K C Cooper
Journal:  Xenotransplantation       Date:  2012 Jul-Aug       Impact factor: 3.907

Review 10.  Immunobiology of liver xenotransplantation.

Authors:  Burcin Ekser; Christopher Burlak; Joshua P Waldman; Andrew J Lutz; Leela L Paris; Massimiliano Veroux; Simon C Robson; Michael A Rees; David Ayares; Bruno Gridelli; A Joseph Tector; David Kc Cooper
Journal:  Expert Rev Clin Immunol       Date:  2012-09       Impact factor: 4.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.